Clinical Trial Update: Effect of Addition of Dronedarone to Standard Rate Control Therapy on Ventricular Rate During Persistent Atrial Fibrillation (AFRODITE) [Phase 4]

View source ↗

Summary

This clinical trial update reports the Phase 4 AFRODITE study evaluating whether adding dronedarone to standard rate-control therapy affects ventricular rate in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• Multaq (dronedarone)

Snippet

Sponsor: Sanofi | Conditions: Atrial Fibrillation | Phase 4 | Status: COMPLETED